Stratified Medicine and Reimbursement Issues

Stratified Medicine (SM) has the potential to target patient populations who will most benefit from a therapy while reducing unnecessary health interventions associated with side effects. The link between clinical biomarkers/diagnostics and therapies provides new opportunities for value creation to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fugel, Hans-Joerg, Nuijten, Mark, Postma, Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471319/
https://www.ncbi.nlm.nih.gov/pubmed/23087645
http://dx.doi.org/10.3389/fphar.2012.00181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471319/
https://www.ncbi.nlm.nih.gov/pubmed/23087645
http://dx.doi.org/10.3389/fphar.2012.00181

Ejemplares similares